SLC7A11 and osteosarcoma: In conclusion, our results suggest a novel mechanism whereby super-enhancer-driven MLX rewires cysteine metabolism in osteosarcoma cells through SLC7A11 to cope with oxidative stress, which holds promise for therapeutic development in osteosarcoma.